产品详情
简单介绍:
重组人三叶因子3蛋白与其它公司提供的重组蛋白不同,rHuTFF3蛋白产品为采用CFS的无细胞麦胚蛋白合成系统表达出来的重组蛋白,可表达出对细胞有毒性、易被蛋白酶降解的蛋白;并获得具有良好的可溶性,并有翻译后修饰、从而部分具有功能的蛋白.同时独有的全自动蛋白纯化技术则简便高效,将蛋白纯化过程中对蛋白的损伤降低到*小程度.重组人三叶因子3蛋白(全长序列)产品可用于Western Blot验证、抗体制备、蛋白检测、ELISA等试验中.
详情介绍:
重组人三叶因子3蛋白
Synonyms | Intestinal Trefoil Factor, hITF, Polypeptide P1.B, hP1.B |
Species | Human |
Accession | Q07654 |
GeneID | 7033 |
Source | 重组人三叶因子3蛋白Escherichia coli. |
Molecular Weight | Approximately 13.2 kDa, a homodimeric protein consisting of two 59 amino acid chains, which includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds. |
Quantity | 5µg/20µg/1000µg |
AA Sequence | EEYVGLSANQ CAVPAKDRVD CGYPHVTPKE CNNRGCCFDS RIPGVPWCFK PLQEAECTF |
Purity | 重组人三叶因子3蛋白> 97 % by SDS-PAGE and HPLC analyses. |
Biological Activity | Fully biologically active when compared to standard. The ED50as determined by a chemotaxis bioassay using human MCF-7 cells is less than 10 μg/ml, corresponding to a specific activity of > 100 IU/mg. |
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation | 重组人三叶因子3蛋白Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4. |
Endotoxin | Less than 1 EU/μg of rHuTFF3 as determined by LAL method. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
Storage | This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles. |
重组人三叶因子3蛋白 | |
SDS-PAGE | |
Reference | 1. Seib T, Blin N, Hilgert K, et al. 1997. Genomics, 40: 200-2. 2. Kirikoshi HandKatoh M. 2002. Int J Oncol, 21: 655-9. 3. Lu R, Wang X, Chen JP, et al. 2010. Sichuan Da Xue Xue Bao Yi Xue Ban, 41: 114-7. 4. Jagla W, Wiede A, Dietzmann K, et al. 2000. FASEB J, 14: 1126-31. 5. Takano TandYamada H. 2009. Endocr J, 56: 9-16. |
Background | Trefoil factor 3 encoded by the TFF3 gene in humans, belongs to the trefoil factor family that consists of three members named TFF1, TFF2 and TFF3. They are characterized by having at least one copy of the trefoil motif, a 40-amino acid domain that contains three conserved disulfides. TFF-3 is expressed by goblet cells and in the uterus, and has also been shown to express in certain cancers, including colorectal, hepatocellular, and in biliary tumors. It involves in the maintenance and repair of the intestinal mucosa, also promotes the mobility of epithelial cells in healing processes. TFF3 overexpression is crucial for progression in mouse and human hepatocellular carcinogenesis. TFF3 may be useful as a molecular marker for certain types of cancer, but its role, if any, in tumorigenesis is unknown. |